GleamWall
中文EN

ODYY Odyssey Health, Inc.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1626644 · Fiscal year ends 07/31

Financial factors as of 2026-07-31 (2026Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-228.8%
TTM EPS YoY-150.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-5,799.8%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets8,303.6%
Debt / equity—
Current ratio0.01x
Interest coverage-0.58x

Cash quality & payout

Operating cash flow / net income0.18x
Accruals ratio-4,740.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-07-31FY20252025-07-31
Income statement
Revenue——
R&D expense$0$22,625
SG&A expense$912,994$1.02M
Operating income-$912,994-$1.02M
Interest expense$1.58M$252,516
Income tax$0$0
Net income-$5.73M-$1.74M
EPS (basic)-0.05-0.02
EPS (diluted)-0.05-0.02
Weighted avg. shares (diluted)108.32M104.71M
Balance sheet
Cash & equivalents$122,361$19,084
Current assets$147,859$49,723
Total assets$147,859$49,723
Current liabilities$12.28M$7.00M
Total liabilities$12.28M$7.00M
Shareholders' equity-$12.13M-$6.95M
Shares outstanding105.97M96.71M
Cash flow statement
Operating cash flow-$1.05M-$347,392
Investing cash flow$0$69,787
Financing cash flow$1.15M$294,310
Stock-based compensation$5,408$108,399

Free plan shows the latest 2 periods; Pro shows all 12 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.